Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients - KFF Health News

A 2024 state law reclassified misoprostol and mifepristone as controlled substances. That affects how hospitals can access the drugs in non-abortion emergencies, and other states appear to be taking note.

Raccontata dakffhealthnews.org